15-min delayed · Aug 25, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 1 firms covering PAVmed Inc, 1 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets are tightly clustered, $56.00 to $56.00, so the covering firms are broadly aligned. The average target of $56.00 sits 955% above the current $5.31. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.61 next quarter toward $-2.45 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS1 ratings
Strong Buy
Strong Buy00%
Buy1100%
Hold00%
Sell00%
Strong Sell00%
Based on 1 analysts giving stock ratings to PAVmed Inc.
As of Aug, 1 of 1 firms rate PAVM a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
PAVM EPS & revenue forecast
EPS · NEXT QUARTER
$-0.61
Range $-0.61 – $-0.61 · 1 analysts · -42% YoY
Next period, 1 analysts expect PAVmed Inc to earn $-0.61 a share (range $-0.61 – $-0.61), versus $-1.05 a year earlier. Full-year consensus is $-2.62, growing to $-2.45 the year after.
REVENUE · NEXT QUARTER
$60.0K
Range $60.0K – $60.0K · 1 analysts · +15% YoY
Revenue is expected to reach $60.0K (range $60.0K – $60.0K), +15.4% year-over-year. Full-year consensus is $165.0K, rising to $600.0K next year.
Top analysts covering PAVmed Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on PAVM.
#1
Edward Woo
Ascendiant Capital · Rank #419
Buy
$56.00+954.6% to target
Overall win rate
25%
+ Follow
PAVM stock forecast FAQ
What is PAVM's average 12-month price target?+
The 1 analysts with a live target average $56.00 for PAVmed Inc over the next 12 months, ranging from a $56.00 high to a $56.00 low.
Is PAVM stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 1 analyst ratings, 1 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
How many Wall Street analysts cover PAVM?+
1 analysts have an active rating on PAVmed Inc, and 1 firms carry a live 12-month price target.
Who is the most accurate analyst covering PAVM?+
Among analysts who currently cover PAVM, Edward Woo of Ascendiant Capital has the strongest overall Quantellect track record (Rank #419). Their current call is Buy with a $56.00 target.
What is PAVmed Inc's projected EPS for next quarter?+
The consensus estimate is $-0.61 per share (range $-0.61 – $-0.61) across 1 analysts. Full-year EPS is projected at $-2.62, rising to $-2.45 the following year.
How much revenue is PAVmed Inc expected to report next quarter?+
Consensus revenue is $60.0K (range $60.0K – $60.0K). Full-year revenue is projected at $165.0K, growing to $600.0K next year.
Have analysts been upgrading or downgrading PAVM lately?+
As of Aug, 1 of 1 firms rate PAVM a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their PAVM calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
